NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by<i>Escherichia coli</i>Nissle 1917: a Novel Effect of a Probiotic Bacterium
Jan Wehkamp(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Birte Wehkamp-von Meissner(Robert Bosch Hospital), U. Sonnenborn(Ardeypharm (Germany)), Klaus Fellermann(Apple (Israel)), Kai Wehkamp, Sabine Nuding(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Jens‐Michael Schröder(Duke Medical Center), Jürgen Harder(Christian-Albrechts-Universität zu Kiel), Corinne Enders(Ardeypharm (Germany)), Stig Bengmark(Lund University), Miriam Schlee(Robert Bosch Hospital)
Cited by 469
Related Papers
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
|Journal of Biological Chemistry|2001|1.3k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558